can anybody tell me what tdx has going for its, page-3

Cashngrab...what is there to be excited about.

I'll disregard the fact most of us are feeling flat because the company are very slow informing us of their grand plan.

WE are at these levels because no one has any idea of the future, Jenny made sure of that last August with here clinical announcement that killed the SP.

Moving Forward:

SpeeDx License Agreement - This one could be worth a lot of money to the business, will take time. But there is a big need for quick and reliable TB testing.

Neoclone License Agreement - This one is as you suggested, just selling some TB markers they identified along the way for research purposes, not big dollars may provide some cashflows short term.

Sale of Readrite and diagnosticIQ platform, no idea of how much but once again more money in the business.

Bayer Settlement, again no idea how much but more money in the kitty.

BACK DOOR LISTING - Anything could happen here and an entry anything under .005 may bring a good return, once again no idea.

Comes down to what sort of appetite you have for Risk and the potential reward.


Patience is the key.